Delivery Order SPE2DB25D3504-SPE2DB25FVVDD
- Not listed
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This non-competitive delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, operates under a firm fixed-price arrangement and represents a single-line pharmaceutical procurement to support federal medical supply needs. The award is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by June 2, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication, valued at $3,931.20. This non-set-aside contract was awarded competitively on June 2, 2025, with an ultimate completion date of June 3, 2025, utilizing firm fixed pricing. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a small-value pharmaceutical procurement issued under a non-competitive set-aside arrangement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,153.80 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. This non-set-aside, firm fixed-price delivery order was issued on July 16, 2025, with an ultimate completion date of July 17, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a $33,187.59 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This firm fixed-price contract, awarded on June 25, 2025, with completion scheduled for June 26, 2025, represents a routine pharmaceutical procurement under the agency's medical supply chain operations. The award carries no set-aside designation, indicating competitive procurement from the open market. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVDDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,064.70 to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed price delivery order, awarded on June 17, 2025, with completion scheduled for June 18, 2025, represents a routine pharmaceutical procurement through the federal medical supply chain. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs and other federal medical systems worldwide. The smaller delivery order reflects routine pharmaceutical fulfillment within this expansive master contract framework, supporting the Defense Health Agency and other government healthcare customers' ongoing medication needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/17/25 |